Atlas Trials

Study of Core Needle Biopsy and Cryoablation of an Enlarging Tumor in Patients With Metastatic Lung Cancer and Metastatic Melanoma Receiving Post-progression Immune Checkpoint Inhibitor Therapy

Clinical trial NCT03290677 · COMPLETED

Trial details

NCT number
NCT03290677
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Lung Cancer
Start date
2018-01-17
Primary completion
2023-09-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.